What is the evidence behind Semaglutide?

Evidence grade A, multiple large randomized controlled trials in humans (STEP program). See our grading methodology for what each grade means.

Is Semaglutide available through Peptós.LIFE?

Available now through a clinician. Branded versions are FDA-approved; compounded semaglutide is not FDA-approved and supply is winding down, your clinician decides if it fits.

Is Semaglutide FDA-approved?

A branded version of Semaglutide is FDA-approved. Compounded versions are not FDA-approved.

Peptide Knowledge Base · Metabolic

Semaglutide: what it is, what the evidence says, and its real status

Short version

A GLP-1 medicine that lowers appetite and blood sugar, the most-studied molecule in the whole category.

AvailableEvidence grade A · Strong human evidence

That’s the honest answer. Everything below is the detail.

This is the real, trial-grade end of 'peptides.' Large randomized human trials, FDA-approved branded versions, and a compounded route under clinician care. We talk about the path, not just the molecule.

Can you actually get it?

Plain-English verdict: Available.

Regulatory status: 503A / shortage-exception pathway.

How does Semaglutide work?

A GLP-1 receptor agonist that slows gastric emptying and signals satiety, reducing appetite and improving glycemic control.

What it does — and what it does not do

What it does: Reduces appetite and supports meaningful weight loss and blood-sugar control, with the strongest human evidence in the category.

What it does not do: It is not a cosmetic shortcut and not risk-free; compounded forms are not FDA-approved, and we make no guaranteed-loss claims.

How honest is the evidence?

Evidence grade A — Strong human evidence.

multiple large randomized controlled trials in humans (STEP program)

A grade measures how much human evidence exists, not whether a molecule is good, safe, or worth your interest. Read our grading methodology for what each grade means.

What we still don't know: Long-term outcomes of compounded (vs. branded) formulations are less characterized; durability after stopping depends heavily on the habits built alongside it.

WADA status: Not prohibited.

How it is taken

What the literature reports: weekly subcutaneous, titrated slowly. Educational only, your clinician sets any dose.

Who should not take it

Personal/family history of medullary thyroid carcinoma or MEN-2; pregnancy. Discuss GI and gallbladder history with a clinician.

Sources

Wilding et al., STEP trials (NEJM 2021) · FDA labeling (Wegovy/Ozempic)

Compounded medications are not FDA-approved. We keep two signals separate and never collapse them: whether you can get something, and what the rule currently says. See the live FDA Peptide Tracker for status.

Join the founding list →

Embed this card on your site · free, CC BY 4.0, no key.

Last reviewed Jun 16, 2026 · Peptós.LIFE · Not medical advice.

Cite this page

Semaglutide. Peptós.LIFE Peptide Knowledge Base. Reviewed Jun 16, 2026. https://peptos.life/peptides/semaglutide

Free to reuse under CC BY 4.0, with attribution and a link. Machine-readable: JSON · CSV · what is in the export.